title: Travel medicine and the solid-organ transplant recipient.
abstract: More than a quarter of solid-organ transplant recipients are traveling to foreign regions where there are greater health risks than their home country. There may be higher risk of complications from typical travel-related illnesses and risk of opportunistic infections not faced by healthy travelers. Some vaccinations may be contraindicated after solid-organ transplant, and those that are safe may have decreased efficacy. Drug interactions between antirejection regimens and medications for malaria prophylaxis and traveler's diarrhea must be considered. This article discusses how providers can best advise and help protect these high-risk travelers.
authors.affiliation: Medstar Georgetown University Hospital, Division of Infectious Diseases and Travel Medicine, Washington, DC 20007, USA. jdr9@gunet.georgetown.edu
authors.forename: Jessica
authors.initials: J
authors.lastname: Rosen
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods; D003967:Diarrhea / Q000188:drug therapy / Q000473:pathology; D004347:Drug Interactions; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008288:Malaria / Q000517:prevention & control; D019737:Transplants; D014195:Travel; D057236:Travel Medicine / Q000379:methods*; D014611:Vaccination / Q000009:adverse effects / Q000379:methods
chemical_list: D000900:Anti-Bacterial Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents